Said Bassem, Strome Marshall
Department of Otolaryngology and Communicative Disorders, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Ann Otol Rhinol Laryngol. 2003 Mar;112(3):276-9. doi: 10.1177/000348940311200315.
To assess the long-term efficacy and morbidity of radiofrequency volumetric tissue reduction (RFVTR) of the soft palate for snoring, we examined the medical records of 39 patients who received this treatment at an academic medical center. Telephone interviews were conducted with the patients to evaluate the long-term subjective efficacy and sequelae. The average follow-up was 14 months (range, 3 to 26 months). Twenty-eight patients (72%) responded to treatment, defined as a 4-point decrease on a 10-point scale. The self-reported snoring score decreased an average of 52% (8.8 +/- 1.9 to 4.2 +/- 2.9). Sixty-seven percent of the patients were satisfied. The response to treatment did not always correlate with patient satisfaction. The snoring relapse rate was 11% among responders. No significant differences were identified between responders and nonresponders. No significant complications or long-term sequelae were observed. We conclude that RFVTR of the palate is a relatively safe and effective long-term treatment for snoring. Defining realistic pretreatment expectations is important in maximizing patient satisfaction.
为评估软腭射频容积性组织减容术(RFVTR)治疗打鼾的长期疗效和发病率,我们查阅了在一家学术医疗中心接受该治疗的39例患者的病历。对患者进行电话随访以评估长期主观疗效和后遗症。平均随访时间为14个月(范围3至26个月)。28例患者(72%)治疗有效,定义为在10分制量表上降低4分。自我报告的打鼾评分平均降低52%(从8.8±1.9降至4.2±2.9)。67%的患者表示满意。治疗反应并不总是与患者满意度相关。反应者中的打鼾复发率为11%。反应者与无反应者之间未发现显著差异。未观察到明显并发症或长期后遗症。我们得出结论,软腭RFVTR是一种相对安全有效的打鼾长期治疗方法。明确现实的治疗前预期对于最大化患者满意度很重要。